New Patent Filed for EmtinB With Copaxone as Potential MS Therapy
NeuroScientific Biopharmaceuticals has filed a patent in Australia to protect the use of its lead candidate EmtinB in combination…
Articles by Margarida Maia, PhD
Newer Neurologic Therapies Costly, Less Likely to Be Used
Fewer than 1 in 5 people living with multiple sclerosis (MS) or 10 other neurological conditions in the U.S.
Eating Lots of Acidic Foods Linked to Worse, Longer Depression in MS
Eating a lot of acidic foods like meat, eggs, cheese, and grains — and fewer alkaline ones, such as fruits,…
Good Immune Responses to CMV Infection Linked to Better Outcomes
People with good immune responses against the human cytomegalovirus (CMV), a common herpes virus, around the time of their first…
SPMS Patients on Mayzent Show Stable Disease in Real-world Study
Almost two-thirds of a group of 108Â secondary progressive multiple sclerosis (SPMS) patients being treated with Mayzent (siponimod) remained…
How Nasal Foralumab Affects Healthy Immune System: Study
Foralumab nasal spray, an experimental therapy by Tiziana Life Sciences that’s being tested for multiple sclerosis and…
Trial to Assess Adherence to PoNS Therapy for MS With at-Home Use
An upcoming observational clinical trial will assess how adherence to treatment with the portable neuromodulation stimulator (PoNS) device, used…
Expanded Access Program of Nasal Foralumab Enrolls 4 SPMS Patients
A group of four patients have entered a special program where they’ll gain access to foralumab nasal spray, an…
NMSS Grant Supports Work Into Epstein-Barr Virus as MS Trigger
A National Multiple Sclerosis Society grant is supporting an Australian-led research team aiming to better understand how the Epstein-Barr virus…
4 Weeks of Nabiximols Found to Ease Spasticity in MS Pilot Study
Four weeks of treatment with nabiximols — an oral spray containing compounds found in the cannabis plant — significantly reduced…
NIH Grant to Test ‘Shaky’ Treadmill Training to Prevent Falls With MS
A research team at Marquette University has received a $3.34 million grant from the National Institutes of Health (NIH) to test…
Iron Rim Lesions in Brain Linked to a More Severe Disease Course
The presence of iron rim lesions, which are regions of chronic inflammation seen on MRI scans, may be linked to…
High-intensity Resistance Training May Help MS Patients With Fatigue
Three months of once-weekly sessions of high-intensity resistance training — consisting of strength exercises followed by a short recovery between…
Research Collaboration to Study COVID-19 Vaccine Dosing, Timing
The Accelerated Cure Project (ACP) for multiple sclerosis (MS) is teaming up with Quest Diagnostics to study…
Eye Scans May Help to Diagnose MS in Children
A machine learning approach based on eye scans was employed by researchers to diagnose multiple sclerosis (MS) in children…
RRMS Onset Taking Place at Older Ages Over Past 50 Years
The first symptoms of relapsing-remitting multiple sclerosis (RRMS) have been appearing increasingly later in life, according to a Spanish…
Natalizumab, Biosimilar of Tysabri for Relapsing MS, Under FDA Review
The U.S. Food and Drug Administration (FDA) has agreed to review an application requesting that Polpharma Biologics‘ natalizumab, a…
Case Suggests Soliris as Potential Treatment for Progressive MS
Note: This story was updated July 20, 2022, to correct the headline to reflect that Soliris might be a…
Uncontrolled Hypertension More Likely in Black Americans With MS
Black Americans with multiple sclerosis (MS) have a higher chance of having uncontrolled…
High Immune Cell Counts in Blood May Be Linked to MS, Study Finds
Higher numbers of immune cells circulating in the bloodstream may mean a greater likelihood of developing multiple sclerosis (MS),…
Dysport Wins Positive Opinion in Europe for Treating Bladder Issues
Dysport (abobotulinumtoxinA), a form of purified botulinum toxin, has received a positive opinion in Europe for managing urinary incontinence…
Past Childhood Abuse Linked to Increased MS Risk in Norwegian Study
Women who were exposed to sexual or emotional abuse as children may be at an increased risk of developing multiple sclerosis…
UCSF Researcher Earns Scientific Breakthrough Award
This year’s Scientific Breakthrough Award, funded by the American Brain Foundation, has been awarded to Stephen Hauser, MD, for…
COVID-19 Not Linked to Long-term Worsening of RRMS: Iranian Study
COVID-19 does not seem to be linked to increased disability worsening or more relapses in the long term for people…
MS Research Prize Goes to Barcelona Neurologist
A researcher in Barcelona, Spain, has been chosen to receive the 2022 John Dystel Prize for his work advancing…
PIPE-307, Aiming to Restore Myelin, Found Safe in Phase 1 Trial
PIPE-307, an investigational myelin-restoring medication being developed by Pipeline Therapeutics for the treatment of multiple sclerosis (MS), appears…
Blood Stem Cell Transplant May Help Immune System Longer
Treatment with an autologous hematopoietic stem cell transplant (aHSCT) seems to reboot the immune system in multiple sclerosis (MS)…
Researcher Will Use Award to Find Biomarkers of RIS in Children
This year’s Harry Weaver Neuroscience Scholar Award, funded by the National Multiple Sclerosis (MS) Society, has gone to a…
Tevogen to Develop T-cell Therapy That Might Prevent EBV Infection
Tevogen Bio is planning to make use of its virus-fighting immune cell technology and turn it against Epstein-Barr virus…
Real-World Data Shows Tecfidera Comparable to Gilenya at Preventing Relapses
Tecfidera (dimethyl fumarate) appears to have similar benefits to Gilenya (fingolimod) in preventing relapses and the loss of…